Analyst Information


Edward Tenthoff

Sr Research Analyst

Edward Tenthoff

Ted Tenthoff is a managing director and senior research analyst at Piper Sandler, focused on the drug discovery sector of the biotech industry. In April 2013 and 2015, Tenthoff moderated panels at the International Adult Stem Cell Conference at the Vatican. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Sandler in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor’s degree in international relations from the University of Pennsylvania.

Universe Coverage:
Healthcare:   Biotechnology
AGLEAeglea Biotherapeutics, Inc.
ALNYAlnylam Pharmaceuticals, Inc.
APVOAptevo Therapeutics Inc.
APTOAptose Biosciences, Inc.
ARAVAravive, Inc.
ARWRArrowhead Pharmaceuticals
ARVNArvinas Inc.
ASLNAslan Pharmaceuticals Ltd.
LIFEaTyr Pharma, Inc.
BCYCBicycle Therapeutics Ltd.
IPSCCentury Therapeutics, Inc.
CCXIChemoCentryx, Inc.
CRSPCRISPR Therapeutics AG
DYNDyne Therapeutics, Inc.
FATEFate Therapeutics, Inc.
FULCFulcrum Therapeutics, Inc.
GMDAGamida Cell Ltd.
INFIInfinity Pharmaceuticals, Inc.
JNCEJounce Therapeutics, Inc.
KRONKronos Bio, Inc.
KYMRKymera Therapeutics, Inc.
LEGNLegend Biotech Corporation
MESOMesoblast Ltd.
MISTMilestone Pharmaceuticals, Inc.
MRNAModerna, Inc.
GLUEMonte Rosa Therapeutics, Inc.
NXTCNextCure, Inc.
OMGAOmega Therapeutics, Inc.
OPKOPKO Health, Inc.
PNTPOINT Biopharma Global Inc.
PSTXPoseida Therapeutics, Inc.
PRTCPureTech Health Plc
RAPTRapt Therapeutics, Inc.
MCRBSeres Therapeutics, Inc.
STROSutro Biopharma, Inc.
SYRSSyros Pharmaceuticals, Inc.
TPSTTempest Therapeutics, Inc.
XNCRXencor, Inc.